Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection

Completed · Phase 1/Phase 2

Conditions studied: Brain Tumors With Ill-defined Margins

In brief

The purpose of this study is to investigate whether stereotactic indigo carmine injection can safely increase the extent of tumor resection.

Key facts

Study ID

NCT01767415

Run by

Weill Medical College of Cornell University

People needed

10

Starts

2012-04-01

Expected to finish

2014-09-01

Last updated by the study team

2018-12-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with gliomas or other tumors that may have ill defined margins during the operative resection.

You may not qualify if…

• Subjects with a contraindication for brain MRI scan. Subjects who are pregnant, younger than 18 years old or have a contraindication for indigo carmine are excluded as well

Where it is running

• Weill Cornell Medical College Department of Neurological Surgery — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.